spacer
home > pmps > autumn 2017 > pharmas digital journey
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmas Digital Journey

There has been a lot of media attention regarding the term ‘Industry 4.0’, what it means and how it will revolutionise manufacturing in terms of flexibility, productivity, efficiency and customer interaction. The uptake of digital technologies is central to its successful adoption across the UK, and work is underway to ensure this happens.

January 2017 saw the launch of the Industrial Digitalisation Review on the back of the British Government’s Industrial Strategy. It aims to forge a roadmap on how companies in the UK can best adopt cybernetic technologies and make the most of the opportunities the digital industry offers the economy in terms of supporting growth, high value job creation, skills and improving national productivity. The panel will spend time reviewing and talking to stakeholders, influencers and large and small businesses to see how the design, development and deployment of technologies will support and drive Britain’s digital industrial revolution – more commonly referred to as the ‘4th industrial revolution’.

Industry 4.0 is a confluence of several major innovative technologies that are in a state of stability and maturity. These have the ability to transform manufacturing through tools such as robotics, advanced sensors, 3D printing, the Internet of Things, cloud computing, digital fabrication and simulation. Supporting this, new business and marketing models will underpin the new technology and manage a more organic relationship with customers and their requirements, linking all of them to the real world through smartphones, tablets and laptops.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alwyn Jones is Head of Pharmaceutical and Life Sciences at Siemens UK and Ireland, delivering the business strategy for the sector. Prior to joining Siemens, Alwyn worked for some of Siemens’ solution partners, who primarily serviced pharma and other highly regulated sectors.
spacer
Alwyn Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Continues Commitment to Oncology Drug Discovery

Charles River Laboratories International, Inc. (NYSE: CRL) today announced new additions to the Tumor Model Compendium. Charles River’s Compendium provides access to a comprehensive collection of well-established tumor models for early-stage oncology research.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

Biotech Showcase™ 2019

7-9 January 2019, Hilton San Francisco Union Square

Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement